The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.10
Bid: 3.00
Ask: 3.20
Change: 0.00 (0.00%)
Spread: 0.20 (6.667%)
Open: 3.10
High: 3.10
Low: 3.10
Prev. Close: 3.10
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Dec 2022 13:06

RNS Number : 9449I
ValiRx PLC
07 December 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

gb00blh13c52

Issuer Name

VALIRX PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

nicholas slater

City of registered office (if applicable)

mill hill

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

07-Dec-2022

6. Date on which Issuer notified

07-Dec-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.530000

0.000000

4.530000

4087345

Position of previous notification (if applicable)

4.040000

1.760000

5.800000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BLH13C52

3286445

800900

3.640000

0.890000

Sub Total 8.A

4087345

4.530000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

reduced to 4.53%

12. Date of Completion

07-Dec-2022

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUBRORUSUURAA
Date   Source Headline
12th May 20084:42 pmPRNStatement re Placing of Shares
8th May 20088:05 amRNSIssue of Equity
7th May 20082:20 pmRNSHolding(s) in Company
2nd May 200811:35 amRNSResult of EGM
30th Apr 20087:00 amRNSTotal Voting Rights
7th Apr 20085:13 pmRNSNotice of EGM and Placing
18th Mar 20087:50 amPRNValibio Research Update
13th Feb 20087:55 amPRNLetter of Intent
29th Jan 20087:00 amPRNAustralian GeneICE Patent Granted
23rd Jan 20087:00 amPRNMorphogenesis Update
17th Jan 20087:00 amPRNGeneICE – CRT Research Update
31st Dec 20077:00 amRNSTotal Voting Rights
12th Dec 200711:08 amRNSCollaboration Update
12th Dec 20078:31 amPRNPhysiomics Collaboration Update
11th Dec 20077:00 amPRNValiBIO Update
27th Nov 20079:27 amPRNIssue of Equity
12th Nov 20077:00 amPRNEuropean Technology Patent for Nucleosomics
25th Oct 20074:00 pmPRNDirectorate Change
15th Oct 20077:00 amPRNLicense Agreement
28th Sep 200710:00 amPRNInterim Report
28th Sep 20077:01 amRNSTotal Voting Rights
26th Sep 20073:31 pmRNSIssue of Equity
21st Sep 20074:09 pmRNSPlacing
10th Sep 20077:00 amPRNGeneICE CRT update
17th Aug 20076:07 pmRNSAIM Rule 26 Information
8th Aug 20077:00 amPRNEuropean GeneICE Patent Granted and CRT Trials Update
31st Jul 20074:10 pmRNSTotal Voting Rights
27th Jul 200710:27 amRNSResult of AGM
19th Jul 20077:00 amPRNJoint Venture
18th Jul 20072:16 pmRNSIssue of Equity
25th Jun 20072:00 pmPRNFinal Results
12th Jun 200712:00 pmPRNValiRx partners with Clarity Imaging
14th May 20077:00 amPRNCRT / Cronos agreement extension
26th Apr 20077:00 amPRNUS GeneICE Patent Granted
18th Apr 20077:00 amPRNResearch & Development Update
4th Apr 20077:00 amPRNUniversity of Surrey - Collaborative Agreement
27th Mar 20073:45 pmRNSChange of address
15th Feb 20077:00 amPRNPhysiomics plc - Agreement
9th Jan 200712:10 pmPRNAppointment of Non-Executive Director
22nd Dec 200611:40 amRNSTotal Voting Rights
11th Dec 20067:00 amRNSIntended Grant of Patent
4th Dec 20067:00 amRNSMorphogenesis Inc
3rd Oct 20067:00 amRNSAdditional Listing
2nd Oct 20062:33 pmRNSResult of EGM
29th Sep 20061:03 pmRNSConfirmation of Share Capital
26th Sep 20064:46 pmRNSInterim Results
18th Sep 20064:36 pmRNSSchedule 1 - Azure Holdings
11th Sep 20067:00 amRNSRestoration - Azure Holdings
11th Sep 20067:00 amRNSPropsd Aqstn & Notice of EGM
4th Aug 200611:06 amRNSConvertible Loan Note Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.